Cymbalta approved for chronic musculoskeletal pain

FDA approved an sNDA from Eli Lilly and Co. (NYSE:LLY) to expand the label of Cymbalta duloxetine to include the treatment of chronic musculoskeletal pain. In August an FDA advisory committee voted 8-...